Neonatal CD19+B220lo cells sense microbiota via TLR2/4 activation driving proliferation and differentiation - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Neonatal CD19+B220lo B Cells Respond to Microbiota Through TLR2/4 Activation, Promoting Their Proliferation and Differentiation

  • By

  • Carolina Ruiz-Sánchez

  • Isabel Cortegano

  • Mercedes Rodríguez

  • Rodrigo Sanchez-Tarjuelo

  • Alejandro Arrabal

  • M. Carmen Prado

  • Mario Alia

  • M.Pilar Jiménez

  • Victor Manuel Lopez Molina

  • Sara Monzón

  • Victoria López-Alonso

  • Belén de Andrés

  • Maria-Luisa Gaspar

  • June 19, 2026

Share

Clinical Scorecard: Neonatal CD19+B220lo B Cells Respond to Microbiota Through TLR2/4 Activation, Promoting Their Proliferation and Differentiation

At a Glance

CategoryDetail
ConditionNeonatal respiratory infections
Key MechanismsActivation of CD19+B220lo B cells via TLR2 and TLR4 leading to proliferation and differentiation.
Target PopulationNeonates
Care SettingNeonatal intensive care and immunology research

Key Highlights

  • CD19+B220lo B cells in neonatal lungs respond to microbiota through TLR2/4 activation.
  • In vitro stimulation with TLR ligands induces proliferation and differentiation of these B cells.
  • Higher frequency of CD138+ cells observed in CD19+B220lo populations post TLR stimulation.
  • Lung cultures exhibit an inflammatory cytokine profile, contrasting with the regulatory profile in spleen cultures.
  • Antibiotic treatment alters the number and immunoglobulin repertoire of neonatal B cells.

Guideline-Based Recommendations

Diagnosis

  • Assess B cell populations in neonatal respiratory infections.

Management

  • Consider the role of microbiota in neonatal immune responses.

Monitoring & Follow-up

  • Monitor cytokine profiles in lung and spleen cultures.

Risks

  • Antibiotic treatment may reduce beneficial B cell populations.

Patient & Prescribing Data

Neonates at risk of respiratory infections.

Understanding TLR pathways may inform therapeutic strategies.

Clinical Best Practices

  • Evaluate the impact of microbiota on neonatal immune development.
  • Utilize TLR ligands in research to study B cell activation.

Related Resources & Content

Original Source(s)

Neonatal CD19+B220lo cells sense microbiota via TLR2/4 activation driving proliferation and differentiation

  • by Carolina Ruiz-Sánchez, Isabel Cortegano, Mercedes Rodríguez, Rodrigo Sanchez-Tarjuelo, Alejandro Arrabal, M. Carmen Prado, Mario Alia, M.Pilar Jiménez, Victor Manuel Lopez Molina, Sara Monzón, Victoria López-Alonso, Belén de Andrés, Maria-Luisa Gaspar

  • June 19, 2026

Related Content

Are law enforcement death rates rising?

Death-certificate data showed increases among adults and children over 2 decades, with Black males consistently recording the highest rates.

Dexamethasone may reduce severe ROP

Topical treatment numerically reduced progression to treatment-requiring retinopathy of prematurity in a randomized trial, although the primary endpoint was not met.

Eyes of the Young

Dr. Amanda Nanasy explains how a recent Alcon survey reveals unexpected gaps in US teen and young adult eye care

  • August 19, 2026

  • 6 min